Mechanism of activation-induced downregulation of mitofusin 2 in human peripheral blood T cells

Journal of Immunology

Volumn 195, Issue 12, 2015, Pages 5780-5786

  Dasgupta, Asish ^a   Chen, Kuang Hueih ^a   Munk, Rachel B ^a   Sasaki, Carl Y ^a   Curtis, Jessica ^a   Longo, Dan L ^a   Ghosh, Paritosh ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOFUSIN 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; A 443654; CHROMONE DERIVATIVE; GUANOSINE TRIPHOSPHATASE; INDAZOLE DERIVATIVE; INDOLE DERIVATIVE; MFN2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; MORPHOLINE DERIVATIVE; MTOR PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL CYCLE G0 PHASE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; DOWN-REGULATION; GTP PHOSPHOHYDROLASES; HUMANS; INDAZOLES; INDOLES; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MITOCHONDRIAL PROTEINS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIROLIMUS; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES;

EID: 84958267789     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501023     Document Type: Article

References (30)

1. Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65: 801-847.
2. de Brito, O. M., and L. Scorrano. 2008. Mitofusin 2 tethers endoplasmic retic-ulum to mitochondria. Nature 456: 605-610.
3. de Brito, O. M., and L. Scorrano. 2009. Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras. Mitochondrion 9: 222-226.
4. Züchner, S., I. V. Mersiyanova, M. Muglia, N. Bissar-Tadmouri, J. Rochelle, E. L. Dadali, M. Zappia, E. Nelis, A. Patitucci, J. Senderek, et al. 2004. Mu tations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36: 449-451.
5. Misko, A. L., Y. Sasaki, E. Tuck, J. Milbrandt, and R. H. Baloh. 2012. Mito-fusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration. J. Neurosci. 32: 4145-4155.
6. Hernández-Alvarez, M. I., H. Thabit, N. Burns, S. Shah, I. Brema, M. Hatunic, F. Finucane, M. Liesa, C. Chiellini, D. Naon, et al. 2010. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1alpha/Mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care 33: 645-651.
7. Pich, S., D. Bach, P. Briones, M. Liesa, M. Camps, X. Testar, M. Palaćin, and A. Zorzano. 2005. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14: 1405-1415.
8. Bach, D., S. Pich, F. X. Soriano, N. Vega, B. Baumgartner, J. Oriola, J. R. Daugaard, J. Lloberas, M. Camps, J. R. Zierath, et al. 2003. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278: 17190-17197.
9. Chen, K. H., X. Guo, D. Ma, Y. Guo, Q. Li, D. Yang, P. Li, X. Qiu, S. Wen, R. P. Xiao, and J. Tang. 2004. Dysregulation of HSG triggers vascular prolif-erative disorders. Nat. Cell Biol. 6: 872-883.
10. Guo, X., K. H. Chen, Y. Guo, H. Liao, J. Tang, and R. P. Xiao. 2007. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ. Res. 101: 1113-1122.
11. Chen, K. H., A. Dasgupta, J. Ding, F. E. Indig, P. Ghosh, and D. L. Longo. 2014. Role of mitofusin 2 (Mfn2) in controlling cellular proliferation. FASEB J. 28: 382-394.
12. Sasaki, C. Y., T. J. Barberi, P. Ghosh, and D. L. Longo. 2005. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa} B pathway. J. Biol. Chem. 280: 34538-34547.
13. Rojo, M., F. Legros, D. Chateau, and A. Lombès. 2002. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 115: 1663-1674.
14. Ikezoe, T., C. Nishioka, K. Bandobashi, Y. Yang, Y. Kuwayama, Y. Adachi, T. Takeuchi, H. P. Koeffler, and H. Taguchi. 2007. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk. Res. 31: 673-682.
15. Scholzen, T., and J. Gerdes. 2000. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182: 311-322.
16. Cai, N., S. D. Dai, N. N. Liu, L. M. Liu, N. Zhao, and L. Chen. 2012. PI3K/AKT/mTOR signaling pathway inhibitors in proliferation of retinal pigment epithelial cells. Int. J. Ophthalmol. 5: 675-680.
17. Kurmasheva, R. T., F. C. Harwood, and P. J. Houghton. 2007. Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors. Mol. Cancer Ther. 6: 1620-1628.
18. Ketroussi, F., M. Giuliani, R. Bahri, B. Azzarone, B. Charpentier, and A. Durrbach. 2011. Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway. PLoS One 6: e22776.
19. Ma, X. M., and J. Blenis. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10: 307-318.
20. Lee-Fruman, K. K., C. J. Kuo, J. Lippincott, N. Terada, and J. Blenis. 1999. Characterization of S6K2, a novel kinase homologous to S6K1. Oncogene 18: 5108-5114.
21. Sena, L. A., S. Li, A. Jairaman, M. Prakriya, T. Ezponda, D. A. Hildeman, C. R. Wang, P. T. Schumacker, J. D. Licht, H. Perlman, et al. 2013. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38: 225-236.
22. Leboucher, G. P., Y. C. Tsai, M. Yang, K. C. Shaw, M. Zhou, T. D. Veenstra, M. H. Glickman, and A. M. Weissman. 2012. Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol. Cell 47: 547-557.
23. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79: 551-555.
24. Hatakeyama, M., J. A. Brill, G. R. Fink, and R. A. Weinberg. 1994. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8: 1759-1771.
25. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061.
26. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259-261.
27. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev. 8: 1772-1786.
28. Appleman, L. J., A. Berezovskaya, I. Grass, and V. A. Boussiotis. 2000. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J. Immunol. 164: 144-151.
29. Vitagliano, D., F. Carlomagno, M. L. Motti, G. Viglietto, Y. E. Nikiforov, M. N. Nikiforova, J. M. Hershman, A. J. Ryan, A. Fusco, R. M. Melillo, and M. Santoro. 2004. Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. Cancer Res. 64: 3823-3829.
30. Osaki, L. H., and P. Gama. 2013. MAPK signaling pathway regulates p27 phosphorylation at threonin 187 as part of the mechanism triggered by early-weaning to induce cell proliferation in rat gastric mucosa. PLoS One 8: e66651.